Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyfora Bio is a U.S.-based bioprocessing and life science tools company focused on supplying transfection reagents, lipid excipients, and related materials for advanced therapy development and manufacturing. The company serves developers of cell and gene therapies, viral vectors, and mRNA-based products rather than advancing its own therapeutic drug pipeline. Kyfora Bio operates as a subsidiary and bioprocessing brand of Polysciences, leveraging its parent's long-standing chemical manufacturing and cGMP capabilities. Its offerings span research-grade through GMP-compatible materials intended to support customers from discovery through process development and commercialization. Notable marketed products include transfection reagents such as KyFect - AAV, MAXgene, PEI MAX, and related delivery and formulation materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyfora Bio.